COVID Feel Good-An Easy Self-Help Virtual Reality Protocol to Overcome the Psychological Burden o… (NCT06850376) | Clinical Trial Compass
CompletedNot Applicable
COVID Feel Good-An Easy Self-Help Virtual Reality Protocol to Overcome the Psychological Burden of Coronavirus
Italy36 participantsStarted 2020-04-01
Plain-language summary
This pragmatic trial aims to evaluate whether a weekly self-help virtual reality protocol can help overcome the psychological burden of the COVID-19 pandemic. The protocol is based on 'The Secret Garden' 360° VR video available online (www.covidfeelgood.com) which simulates a natural environment to promote relaxation and self-reflection. The VR experience is combined with daily cognitive and social exercises designed to facilitate critical examination of personal identity, relationships, and coping strategies. The study assesses whether this intervention can reduce anxiety, depression, perceived stress, and hopelessness while improving well-being and social connectedness during pandemic-related restrictions.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult participants (≥18 years)
* Native speakers of the country where they will be enrolled
* Have experienced at least two months of quarantine or isolation related to the coronavirus pandemic
* Provide full, written, informed consent
* Have the availability of a smartphone and a cardboard VR headset
* Availability and agreement of a partner for conducting the self-help component of the treatment
Exclusion Criteria:
* Visual or hearing impairments that can limit the participation in the protocol
* Participants reporting vestibular and/or balance disorders
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in depression, anxiety, and stress levels as measured by Depression Anxiety Stress Scale (DASS-21)
Timeframe: Baseline (Day -7 and Day 0), Post-intervention (Day 7), and 2-week Follow-up (Day 21)
2
Perceived Stress Scale (PSS-10)
Timeframe: Baseline (Day -7 and Day 0), Post-intervention (Day 7), and Follow-up (Day 21)
3
Change in hopelessness levels
Timeframe: Baseline (Day -7 and Day 0), Post-intervention (Day 7), and Follow-up (Day 21)